Zydus Lifesciences told exchanges that the US FDA inspection of its Moraiya plant ended on October 13 with five observations. The inspection ran from 5...
Zydus Cadila has received final approval to marketΒ Diclofenac Sodium Topical Solution, from theΒ US health regulator. It is used forΒ treating signs and symptoms of osteoarthritis of...
Cadila Healthcare’s US subsidiary has received approval forΒ anti-obsessional drug, from the US health regulator. In a filing the company stated that, Zydus Pharmaceuticalst (USA) Inc,...
Zydus Cadila,has received final approval from US health regulator for marketing capsules, which are used in treating overactive bladder with symptoms like urinary frequency. In...
Zydus Group has acquired Melgain brand from Hyderabad based Issar Pharma for an undisclosed amount which would be marketed in India by Liva Healthcare, a...
On Wednesday, Zydus, the pharmaceuticals major has announced receipt of approval to sell chronic pain reliever morphine sulfate tablets from the USFDA (US Food and...